No one expects the machinery of progress to roll backwards, but sometimes it seems that no one is watching the speedometer (or manning the brakes, assuming any exist). Is this a fair assessment? If so, should we be worried — and what can we do about it?
In this feature, experts on technology, risk, science, policy and neuroscience discuss risk, innovation and how our values affect our conceptions of both.
In one five-year period, college athletes suffered more than 10,000 concussions — one-third of them while playing football. But an unusual team-up has recently brought a new, biomarker-based concussion test one step closer.
Mammals might seem like better human stand-ins than a minnow’s striped cousin, but zebrafish resemble us in surprising and useful ways. But zebrafish also offer practical advantages over other model species: They’re cheap, hardy, breed like rabbits on Viagra, and their skin can be made transparent.
Pancreatic cancer is the fourth leading cause of cancer deaths in the United States each year, in part because around four-fifths of cases go undetected until they have reached an advanced stage. But a new, biomarker-based test could soon change all that — and offer a way to monitor treatment outcomes.